Dr. Daniel George is Professor of Medicine and Surgery, Divisions of Medical Oncology and Urology in the Duke University School of Medicine. He also has appointments in the Duke Clinical Research Institute and the Duke Cancer Institute where he is the Director of Genitourinary (GU) Oncology disease-based group and is co-lead of the DCI Center for Prostate and Urologic Cancers. He is an internationally recognized clinical researcher and thought leader in GU Malignancies, with over 200 peer-reviewed publications. His areas of research include new drug development and biomarkers of GU Cancers with an emphasis on signal transduction pathways and cancer disparities. Dr. George is the co-PI of IRONMAN, an international multi-sponsor supported registry in advanced prostate cancer.
Cabazitaxel in Metastatic Prostate Cancer, with an Update on the CARD Trial
with Daniel George, M.D., Professor of Medicine and Surgery, Divisions of Medical Oncology and Urology in the Duke University School of Medicine